Marc Schmalzing, MD

University Hospital Wuerzburg
Würzburg, Germany

June 2000 – June 2012 Medical Doctor at University Hospital Tuebingen, Internal Medicine, Hematology, Rheumatology
August 2012 – March 2022 Consultant, Deputy of head of Rheumatology/Clinical Immunology at University Hospital Wuerzburg, Department of Internal Medicine II
April 2022 – ongoing Consultant, head of Rheumatology/Clinical Immunology at University Hospital Wuerzburg, Department of Internal Medicine II

Presentation(s):

• 2175: Real-World Drug Persistence of GP2015, an Etanercept Biosimilar, in Patients with Rheumatoid Arthritis: Results from the Multi-Country COMPACT Study

  Tuesday, November 14, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.

• 2389: Calprotectin (S100A8/S100A9) and Serumamyloid A Are Not Superior to C Reactive Protein and Erythrocyte Sedimentation Rate in Monitoring Disease Activity in Giant Cell Arteritis – Treated with or Without Tocilizumab

  Tuesday, November 14, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.

• 2411: C-X-C Motif Chemokine Receptor 4-targeted Molecular Imaging in Giant Cell Arteritis – a Head-to-head Comparison with FDG PET

  Tuesday, November 14, 2023
  9:00 AM – 11:00 AM PT

  Disclosure information not submitted.